MarketPulse

diagnostic imaging

7 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Precedence Research

Radiopharmaceuticals Market to Double to $15.21B by 2035 Amid Cancer Surge

Global radiopharmaceuticals market projected to grow from $8.28B (2026) to $15.21B (2035) amid rising cancer and cardiovascular disease incidence.
LLYCAHNVSLNTHSIEGY+1cancer treatmentradiopharmaceuticals
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Philips Wins FDA Clearance for Rembra CT Platform, Expanding High-Speed Imaging Access

Royal Philips secured FDA 510(k) clearance for its Rembra platform, enabling faster CT imaging and radiation therapy planning with capacity for 270 daily exams.
PHGhealthcare technologymedical devices
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Bile Duct Cancer Market Eyes $3.89B by 2030 on Therapy Advances

Global bile duct cancer market projected to reach $3.89B by 2030 from $2.59B in 2025, driven by immunotherapy, AI diagnostics, and rising disease prevalence.
BMYCELGrABBVLLYAZN+1pharmaceutical innovationimmunotherapy
GlobeNewswire Inc.GlobeNewswire Inc.··Radnet, Inc.

RadNet Eyes Digital Health Pivot With Gleamer Acquisition, Posts Record Q4 Revenue

RadNet completed Gleamer SAS acquisition, hosting investor call March 5. Q4 2025 revenue hit $547.7M, up 14.8% YoY.
RDNTacquisitionrevenue growth
GlobeNewswire Inc.GlobeNewswire Inc.··Radnet, Inc.

RadNet Eyes AI Dominance With Record Revenue, Gleamer Acquisition

RadNet reports $547.7M Q4 revenue, up 14.8% YoY, acquires Gleamer to strengthen DeepHealth AI radiology platform as global market leader.
RDNTacquisitionrevenue growth
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Telix Pharmaceuticals Hosts Major PSMA Imaging Webinar as Prostate Cancer Focus Sharpens

Telix Pharmaceuticals announces March 2026 webinar on PSMA-PET/CT imaging innovations, featuring leading oncology experts discussing prostate cancer detection advances.
TLXradiopharmaceuticalsinvestor relations
GlobeNewswire Inc.GlobeNewswire Inc.··Na

RadNet Schedules Q4 2025 Earnings Call for March 2

RadNet scheduled Q4 2025 earnings call for March 2, 2026, to discuss financial performance and operational developments across its imaging center network.
RDNTconference callQ4 2025 results